Literature DB >> 857825

Effects of C. parvum on growth and induction of intracerebral tumours in mice.

D E Osborn, T E Sadler, J E Castro.   

Abstract

An investigation was made into the effect of Corynebacterium parvum therapy on cerebral tumours in mice. I.v. C. parvum caused a slight but significant increase in the survival of BALB/c mice injected intracerebrally (i.c.) with not more than 50 Meth A cells. C. parvum was most effective if given on the same day or 5 days after tumour. If this interval was increased there was no effect. Multiple i.v. injections were no more effective than a single dose. I.v. C. parvum had no influence on the survival of C57BL mice injected i.c. with Lewis tumour cells, and had little effect on the induction of i.c. or s.c. tumours by methylcholanthrene. It was concluded that C. parvum therapy was of little use in the treatment of cerebral tumour in mice. The clinical implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 857825      PMCID: PMC2025340          DOI: 10.1038/bjc.1977.63

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  Immunization against intracerebral transplantation of a glioma in mice.

Authors:  L C SCHEINBERG; K SUZUKI; L M DAVIDOFF; R L BEILIN
Journal:  Nature       Date:  1962-03-24       Impact factor: 49.962

Review 2.  The blood brain barrier: anatomy and physiology.

Authors:  B L Holman
Journal:  Prog Nucl Med       Date:  1972

3.  [Immunology and immunotherapy of cerebral tumors. Current status].

Authors:  P Trouillas
Journal:  Rev Neurol (Paris)       Date:  1973-01       Impact factor: 2.607

4.  In vitro demonstration of cell-mediated immunity to human brain tumors.

Authors:  N L Levy; M S Mahaley; E D Day
Journal:  Cancer Res       Date:  1972-03       Impact factor: 12.701

5.  Accurate identification of experimental pulmonary metastases.

Authors:  H Wexler
Journal:  J Natl Cancer Inst       Date:  1966-04       Impact factor: 13.506

6.  Letter: Methyl-cholanthrene-induced sarcomata in mice after immunisation with Corynebacterium parvum plus syngeneic subcellular membrane fractions.

Authors:  H Baum; M Baum
Journal:  Lancet       Date:  1974-12-07       Impact factor: 79.321

Review 7.  Corynebacterium parvum as an immunotherapeutic anticancer agent.

Authors:  M T Scott
Journal:  Semin Oncol       Date:  1974-12       Impact factor: 4.929

8.  Studies in a tumor spectrum. III. The effect of phosphoramides on the growth of a variety of mouse and rat tumors.

Authors:  K SUGIURA; C C STOCK
Journal:  Cancer Res       Date:  1955-01       Impact factor: 12.701

9.  Inhibition of chemical carcinogenesis by viral vaccines.

Authors:  C E Whitmire; R J Huebner
Journal:  Science       Date:  1972-07-07       Impact factor: 47.728

10.  Glioblastoma multiforme: a controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy.

Authors:  H J Bloom; M J Peckham; A E Richardson; P A Alexander; P M Payne
Journal:  Br J Cancer       Date:  1973-03       Impact factor: 7.640

View more
  1 in total

1.  Immunotherapy using BCG during remission induction and as the sole form of maintenance in acute myeloid leukaemia.

Authors:  G P Summerfield; T J Gibbs; A J Bellingham
Journal:  Br J Cancer       Date:  1979-11       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.